Unlocked Access
FULL SUPPLEMENT: The Role of IL 31 Inhibition in Atopic Dermatitis
September 2026 | Volume 25 | Issue 9 | Department | 154710s1 | Copyright © September 2026
Atopic dermatitis and prurigo nodularis represent the two most burdensome pruritic inflammatory skin diseases encountered in clinical dermatology. While distinct in morphology, chronicity, and epidemi...
Read MoreINDIVIDUAL ARTICLE: Interleukin-31 in Atopic Dermatitis and Prurigo Nodularis: Pathophysiology, Neuroimmune Mechanisms, and Clinical Efficacy of Nemolizumab
September 2026 | Volume 25 | Issue 9 | Supplement Individual Articles | 015471s2 | Copyright © September 2026
Interleukin-31 (IL-31) is a central mediator in atopic dermatitis (AD) and prurigo nodularis (PN), functioning both as the principal pruritogeniccytokine, driving itch through direct...
Read MoreFULL SUPPLEMENT: Real-World Split-Face Case Series of a Phyto Polydeoxyribonucleotide (PDRN) Serum in Integrative Skincare
September 2026 | Volume 25 | Issue 9 | Department | 15490s1 | Copyright © September 2026
Inflammation and photodamage are largely considered the leading contributors to premature skin aging as they lead to decreased collagen content in the skin. Collagen, the most abundant protein in the ...
Read MoreINDIVIDUAL ARTICLE: Real-World Cases Using Phyto Polydeoxyribonucleotide (PDRN) Serum
September 2026 | Volume 25 | Issue 9 | Supplement Individual Articles | 15491s2 | Copyright © September 2026
Background: Integrative skincare refers to a clinician-directed regimen that combines aesthetic procedures with appropriate post-procedure skincare. The novel phyto polydeoxyribo...
Read MoreSafety and Tolerability of Facial Skincare in Children and Adolescents: Clinical Testing and Multigenerational Insights
September 2026 | Volume 25 | Issue 9 | Original Article | 807 | Copyright © September 2026
Background: Pediatric and adolescent interest in facial skincare is increasing, often driven by social media and early exposure to adult-formulated products....
Read MoreA Novel Moisturizer Formulated With Micronized Centella asiatica and Mandelic Acid Improves Mature, Crepey Skin
September 2026 | Volume 25 | Issue 9 | Original Article | 833 | Copyright © September 2026
Background: Dermatoporosis is a condition of fragile, aging skin that manifests as altered pH, wrinkles, laxity, easy bruising, and hyperpigmentation. This study evaluated effica...
Read MoreFULL SUPPLEMENT: Research on Generalized Pustular Psoriasis
August 2026 | Volume 25 | Issue 8 | Department | 63120 | Copyright © August 2026
Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening disease of immunologic dysfunction. The pathophysiology of the disease was not well understood until recently. As a...
Read MoreINDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management
August 2026 | Volume 25 | Issue 8 | Supplement Individual Articles | 63121 | Copyright © August 2026
Observations: Emerging epidemiologic, clinical, and real-world data establish GPP as a distinct disease entity associated with high rates of hospitalization, multisystem involvem...
Read MoreMolluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment
August 2026 | Volume 25 | Issue 8 | Original Article | 717 | Copyright © August 2026
Background: Molluscum contagiosum (MC), caused by the molluscum contagiosum virus, is a common viral skin infection in children. MC may persist for months to years and can substa...
Read MoreUse of an Eczema Moisturizer or Cream Provides Immediate, Sustained Itch Relief in Eczema-Prone Individuals
August 2026 | Volume 25 | Issue 8 | Original Article | 737 | Copyright © August 2026
Background: Eczema is a prevalent, chronic skin condition that affects up to 10% of adults globally and is characterized by recurrent eczematous lesions. Intense itch is often th...
Read MoreEfficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation
July 2026 | Volume 25 | Issue 7 | Original Article | 596 | Copyright © July 2026
Background: Melasma and postinflammatory hyperpigmentation (PIH) are common disorders of hyperpigmentation of key aesthetic concern. This study assessed the efficacy and tolerabi...
Read MoreEvaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans
July 2026 | Volume 25 | Issue 7 | Original Article | 615 | Copyright © July 2026
Background: There are currently no FDA-approved pharmacologic treatments for acanthosis nigricans (AN), a common dermatologic condition characterized by hyperpigmented, velvety p...
Read MoreSafety and Effectiveness of Poly-L-Lactic Acid (PLLA-SCA) for Improvement in the Appearance of Cellulite
July 2026 | Volume 25 | Issue 7 | Original Article | 649 | Copyright © July 2026
Background: Cellulite is related to collagen and elastic tissue degeneration in the dermis and hypodermis. Sculptra® poly-L-lactic acid (PLLA-SCA™) is a regenerative in...
Read MoreA Comparative Analysis of 8 Facial Cleansers Using Corneosurfametry Reveals Differentiated Irritation Potential
July 2026 | Volume 25 | Issue 7 | Original Article | 655 | Copyright © July 2026
Background: Facial cleansers can disrupt the stratum corneum and cause irritation. Selecting a cleanser that is both effective and gentle is foundational to a tailored skincare r...
Read MoreFULL SUPPLEMENT: Emerging Topical Approaches in the Management of Female Pattern Hair Loss
June 2026 | Volume 25 | Issue 6 | Department | 83250s1 | Copyright © June 2026
Alopecia can be categorized as cicatricial and non-cicatricial, with female androgenetic alopecia (AGA) and female pattern hair loss (FPHL) included in the latter category....
Read MoreINDIVIDUAL ARTICLE: Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss
June 2026 | Volume 25 | Issue 6 | Supplement Individual Articles | 83251s3 | Copyright © June 2026
Read MoreSafety and Effectiveness of Two Reconstitution Volumes of Poly-L-Lactic Acid for Correction of Décolletage Wrinkles
June 2026 | Volume 25 | Issue 6 | Original Article | 553 | Copyright © June 2026
Background: Aesthetic patients are increasingly aware of the contrast between rejuvenated facial skin and untreated aging skin of the décolletage, and frequently request c...
Read MoreEfficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 545 | Copyright © June 2026
Background: Clascoterone cream 1% is a topical androgen receptor inhibitor approved for the treatment of acne vulgaris in patients ≥12 years of age. The American Academy of De...
Read MoreEfficacy and Safety of Clascoterone Cream 1% and Clindamycin 1.2%/Benzoyl Peroxide 5% Gel Treatment in Patients With Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 537 | Copyright © June 2026
Background: Clascoterone cream 1% is a topical androgen receptor inhibitor approved to treat acne vulgaris in patients ≥12 years of age. The American Academy of Dermatology re...
Read MoreA Review of the Relationship Between Cutibacterium acnes, Biofilms, and Keratosis Pilaris
June 2026 | Volume 25 | Issue 6 | Features | e53 | Copyright © June 2026
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
